Bone morphogenetic protein 4-a fascinating regulator of cancer cell behavior

Cancer Genetics

Volumn 205, Issue 6, 2012, Pages 267-277

  Kallioniemi, Anne ^a  

^a TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

Author keywords

Bone morphogenetic protein 4; Cancer; Invasion; Migration; Proliferation

Indexed keywords

BONE MORPHOGENETIC PROTEIN; BONE MORPHOGENETIC PROTEIN 4; BONE MORPHOGENETIC PROTEIN RECEPTOR 1A; CISPLATIN; DOXORUBICIN; FLUOROURACIL; OXALIPLATIN; PROTEIN TYROSINE PHOSPHATASE; SECRETED FRIZZLED RELATED PROTEIN 4; SMAD PROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR GATA 6; TRANSCRIPTION FACTOR HOXB7; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; WNT PROTEIN;

ANGIOGENESIS; APOPTOSIS; BLADDER CANCER; BRAIN CANCER; BREAST CANCER; CANCER CELL; CANCER GROWTH; CANCER INHIBITION; CANCER PROGNOSIS; CANCER SUSCEPTIBILITY; CARCINOGENESIS; CELL DIFFERENTIATION; CELL FUNCTION; CELL GROWTH; CELL INVASION; CELL MIGRATION; CELL MOTILITY; CELL PROLIFERATION; COLON CANCER; COLORECTAL CANCER; DRUG TARGETING; EPITHELIAL MESENCHYMAL TRANSITION; GENE MUTATION; GENETIC PREDISPOSITION; GENETIC VARIABILITY; HUMAN; HYPOPHYSIS TUMOR; IN VITRO STUDY; IN VIVO STUDY; LIVER CANCER; LIVER CELL CARCINOMA; LUNG CANCER; MELANOMA; METASTASIS POTENTIAL; NONHUMAN; OVARY CANCER; PHENOTYPE; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; REVIEW; SIGNAL TRANSDUCTION; STOMACH CANCER; ANIMAL; CANCER INVASION; CELL MOTION; COLORECTAL TUMOR; FEMALE; GENETICS; LIVER TUMOR; METASTASIS; NEOVASCULARIZATION (PATHOLOGY); OVARY TUMOR; PATHOLOGY; PHYSIOLOGY;

VERTEBRATA;

ANIMALS; APOPTOSIS; BONE MORPHOGENETIC PROTEIN 4; CARCINOMA, HEPATOCELLULAR; CELL DIFFERENTIATION; CELL MOVEMENT; CELL PROLIFERATION; COLORECTAL NEOPLASMS; EPITHELIAL-MESENCHYMAL TRANSITION; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; HUMANS; LIVER NEOPLASMS; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; NEOVASCULARIZATION, PATHOLOGIC; OVARIAN NEOPLASMS;

EID: 84865858355     PISSN: 22107762     EISSN: 22107770     Source Type: Journal    
DOI: 10.1016/j.cancergen.2012.05.009     Document Type: Review

References (122)

1. Kawabata M., Imamura T., Miyazono K. Signal transduction by bone morphogenetic proteins. Cytokine Growth Factor Rev 1998, 9:49-61.
2. Chang H., Brown C.W., Matzuk M.M. Genetic analysis of the mammalian transforming growth factor-beta superfamily. Endocrine Rev 2002, 23:787-823.
3. Reddi A.H. Bone morphogenetic proteins: an unconventional approach to isolation of first mammalian morphogens. Cytokine Growth Factor Rev 1997, 8:11-20.
4. Wozney J.M., Rosen V., Celeste A.J., et al. Novel regulators of bone formation: molecular clones and activities. Science 1998, 242:1528-1534.
5. Wozney J.M. Overview of bone morphogenetic proteins. Spine 2002, 27:S2-S8.
6. Hogan B.L. Bone morphogenetic proteins: multifunctional regulators of vertebrate development. Genes Dev 1996, 10:1580-1594.
7. Zhao G.Q. Consequences of knocking out BMP signaling in the mouse. Genesis 2003, 35:43-56.
8. Hogan B.L. Bone morphogenetic proteins in development. Curr Opin Genet Dev 1996, 6:432-438.
9. Alarmo E.L., Kallioniemi A. Bone morphogenetic proteins in breast cancer: dual role in tumourigenesis?. Endocr Relat Cancer 2010, 17:R123-R139.
10. Singh A., Morris R.J. The Yin and Yang of bone morphogenetic proteins in cancer. Cytokine Growth Factor Rev 2010, 21:299-313.
11. Thawani J.P., Wang A.C., Than K.D., et al. Bone morphogenetic proteins and cancer: review of the literature. Neurosurgery 2010, 66:233-246.
12. Derynck R., Akhurst R.J., Balmain A. TGF-beta signaling in tumor suppression and cancer progression. Nat Genet 2001, 29:117-129.
13. Siegel P.M., Massague J. Cytostatic and apoptotic actions of TGF-beta in homeostasis and cancer. Nat Rev Cancer 2003, 3:807-821.
14. Massague J., Gomis R.R. The logic of TGFbeta signaling. FEBS Lett 2006, 580:2811-2820.
15. Schmierer B., Hill C.S. TGFbeta-SMAD signal transduction: molecular specificity and functional flexibility. Nat Rev Mol Cell Biol 2007, 8:970-982.
16. Bragdon B., Moseychuk O., Saldanha S., et al. Bone morphogenetic proteins: a critical review. Cell Signal 2011, 23:609-620.
17. Griffith D.L., Keck P.C., Sampath T.K., et al. Three-dimensional structure of recombinant human osteogenic protein 1: structural paradigm for the transforming growth factor beta superfamily. Proc Natl Acad Sci U S A 1996, 93:878-883.
18. Ducy P., Karsenty G. The family of bone morphogenetic proteins. Kidney Int 2000, 57:2207-2214.
19. Constam D.B., Robertson E.J. Regulation of bone morphogenetic protein activity by pro domains and proprotein convertases. J Cell Biol 1999, 144:139-149.
20. Sengle G., Charbonneau N.L., Ono R.N., et al. Targeting of bone morphogenetic protein growth factor complexes to fibrillin. J Biol Chem 2008, 283:13874-13888.
21. Aono A., Hazama M., Notoya K., et al. Potent ectopic bone-inducing activity of bone morphogenetic protein-4/7 heterodimer. Biochem Biophys Res Commun 1995, 210:670-677.
22. Israel D.I., Nove J., Kerns K.M., et al. Heterodimeric bone morphogenetic proteins show enhanced activity in vitro and in vivo. Growth Factors 1996, 13:291-300.
23. Shi Y., Massague J. Mechanisms of TGF-beta signaling from cell membrane to the nucleus. Cell 2003, 113:685-700.
24. Miyazono K., Kamiya Y., Morikawa M. Bone morphogenetic protein receptors and signal transduction. J Biochem 2010, 147:35-51.
25. Nohe A., Keating E., Knaus P., et al. Signal transduction of bone morphogenetic protein receptors. Cell Signal 2004, 16:291-299.
26. de Caestecker M. The transforming growth factor-beta superfamily of receptors. Cytokine Growth Factor Rev 2004, 15:1-11.
27. ten Dijke P., Korchynskyi O., Valdimarsdottir G., et al. Controlling cell fate by bone morphogenetic protein receptors. Mol Cell Endocrinol 2003, 211:105-113.
28. Sebald W., Nickel J., Zhang J.L., et al. Molecular recognition in bone morphogenetic protein (BMP)/receptor interaction. Biol Chem 2004, 385:697-710.
29. Attisano L., Wrana J.L. Smads as transcriptional co-modulators. Curr Opin Cell Biol 2000, 12:235-243.
30. Feng X.H., Derynck R. Specificity and versatility in tgf-beta signaling through Smads. Annu Rev Cell Dev Biol 2005, 21:659-693.
31. Massague J., Seoane J., Wotton D. Smad transcription factors. Genes Dev 2005, 19:2783-2810.
32. Balemans W., Van Hul W. Extracellular regulation of BMP signaling in vertebrates: a cocktail of modulators. Dev Biol 2002, 250:231-250.
33. Gazzerro E., Canalis E. Bone morphogenetic proteins and their antagonists. Rev Endocr Metab Disord 2006, 7:51-65.
34. ten Dijke P., Goumans M.J., Itoh F., et al. Regulation of cell proliferation by Smad proteins. J Cell Physiol 2002, 191:1-16.
35. Canalis E., Economides A.N., Gazzerro E. Bone morphogenetic proteins, their antagonists, and the skeleton. Endocrine Rev 2003, 24:218-235.
36. Piscione T.D., Phan T., Rosenblum N.D. BMP7 controls collecting tubule cell proliferation and apoptosis via Smad1-dependent and -independent pathways. Am J Physiol Renal Physiol 2001, 280:F19-F33.
37. Hu M.C., Wasserman D., Hartwig S., et al. p38MAPK acts in the BMP7-dependent stimulatory pathway during epithelial cell morphogenesis and is regulated by Smad1. J Biol Chem 2004, 279:12051-12059.
38. Kimura N., Matsuo R., Shibuya H., et al. BMP2-induced apoptosis is mediated by activation of the TAK1-p38 kinase pathway that is negatively regulated by Smad6. J Biol Chem 2000, 275:17647-17652.
39. Otani H., Otsuka F., Inagaki K., et al. Antagonistic effects of bone morphogenetic protein-4 and -7 on renal mesangial cell proliferation induced by aldosterone through MAPK activation. Am J Physiol Renal Physiol 2007, 292:F1513-F1525.
40. Attisano L., Labbe E. TGFbeta and Wnt pathway cross-talk. Cancer Metastasis Rev 2004, 23:53-61.
41. Herpin A., Cunningham C. Cross-talk between the bone morphogenetic protein pathway and other major signaling pathways results in tightly regulated cell-specific outcomes. FEBS J 2007, 274:2977-2985.
42. Winnier G., Blessing M., Labosky P.A., et al. Bone morphogenetic protein-4 is required for mesoderm formation and patterning in the mouse. Genes Dev 1995, 9:2105-2116.
43. Sadlon T.J., Lewis I.D., D'Andrea R.J. BMP4: its role in development of the hematopoietic system and potential as a hematopoietic growth factor. Stem Cells 2004, 22:457-474.
44. Bellusci S., Henderson R., Winnier G., et al. Evidence from normal expression and targeted misexpression that bone morphogenetic protein (Bmp-4) plays a role in mouse embryonic lung morphogenesis. Development 1996, 122:1693-1702.
45. Robert B. Bone morphogenetic protein signaling in limb outgrowth and patterning. Dev Growth Differ 2007, 49:455-468.
46. Bénazet J.D., Bischofberger M., Tiecke E., et al. A self-regulatory system of interlinked signaling feedback loops controls mouse limb patterning. Science 2009, 323:1050-1053.
47. Haramis A.P., Begthel H., van den Born M., et al. De novo crypt formation and juvenile polyposis on BMP inhibition in mouse intestine. Science 2004, 303:1684-1686.
48. Miyazaki Y., Oshima K., Fogo A., et al. Evidence that bone morphogeneticprotein 4 has multiple biological functions during kidney and urinary tract development. Kidney Int 2003, 63:835-844.
49. Schedl A. Renal abnormalities and their developmental origin. Nat Rev Genet 2007, 8:791-802.
50. Danesh S.M., Villasenor A., Chong D., et al. BMP and BMP receptor expression during murine organogenesis. Gene Expr Patterns 2009, 9:255-265.
51. Weber S., Taylor J.C., Winyard P., et al. SIX2 and BMP4 mutations associate with anomalous kidney development. J Am Soc Nephrol 2008, 19:891-903.
52. Kelleher F.C., Fennelly D., Rafferty M. Common critical pathways in embryogenesis and cancer. Acta Oncol 2006, 45:375-388.
53. Howe J.R., Bair J.L., Sayed M.G., et al. Germline mutations of the gene encoding bone morphogenetic protein receptor 1A in juvenile polyposis. Nat Genet 2001, 28:184-187.
54. Howe J.R., Roth S., Ringold J.C., et al. Mutations in the SMAD4/DPC4 gene in juvenile polyposis. Science 1998, 280:1086-1088.
55. Harradine K.A., Akhurst R.J. Mutations of TGFbeta signaling molecules in human disease. Ann Med 2006, 38:403-414.
56. Houlston R.S., Webb E., Broderick P., et al. Meta-analysis of genome-wide association data identifies four new susceptibility loci for colorectal cancer. Nat Genet 2008, 40:1426-1435.
57. Lubbe S.J., Pittman A.M., Olver B., et al. The 14q22.2 colorectal cancer variant rs4444235 shows cis-acting regulation of BMP4. Oncogene 2012, [Epub ahead of print].
58. Slattery M.L., Lundgreen A., Herrick J.S., et al. Genetic variation in bone morphogenetic protein and colon and rectal cancer. Int J Cancer 2012, 130:653-664.
59. Tomlinson I.P.M., Carvajal-Carmona L.G., Dobbins S.E., et al. Multiple common susceptibility variants near BMP pathway loci GREM1, BMP4, and BMP2 explain part of the missing heritability of colorectal cancer. PloS Genet 2011, 7:e1002105.
60. Lubbe S.J., Pittman A.M., Matijssen C., et al. Evaluation of germline BMP4 mutation as a cause of colorectal cancer. Hum Mutat 2011, 32:E1928-E1938.
61. Sneddon J.B., Zhen H.H., Montgomery K., et al. Bone morphogenetic protein antagonist gremlin 1 is widely expressed by cancer-associated stromal cells and can promote tumor cell proliferation. Proc Natl Acad Sci U S A 2006, 103:14842-14847.
62. Kwak C., Park Y.H., Kim I.Y., et al. Expression of bone morphogenetic proteins, the subfamily of the transforming growth factor-beta superfamily, in renal cell carcinoma. J Urol 2007, 178:1062-1067.
63. Kim S.G., Park H.R., Min S.K., et al. Expression of bone morphogenic protein-4 is inversely related to prevalence of lymph node metastasis in gastric adenocarcinoma. Surg Today 2011, 41:688-692.
64. Laatio L., Myllynen P., Serpi R., et al. BMP-4 expression has prognostic significance in advanced serous ovarian carcinoma and is affected by cisplatin in OVCAR-3 cells. Tumour Biol 2011, 32:985-995.
65. Xu T., Yu C.Y., Sun J.J., et al. Bone morphogenetic protein-4-induced epithelial-mesenchymal transition and invasiveness through Smad1-mediated signal pathway in squamous cell carcinoma of the head and neck. Arch Med Res 2011, 42:128-137.
66. Chiu C.Y., Kuo K.K., Kuo T.L., et al. The activation of MEK/ERK signaling pathway by bone morphogenetic protein 4 to increase hepatocellular carcinoma cell proliferation and migration. Mol Cancer Res 2012, 10:415-427.
67. Deng H., Makizumi R., Ravikumar T.S., et al. Bone morphogenetic protein-4 is overexpressed in colonic adenocarcinomas and promotes migration and invasion of HCT116 cells. Exp Cell Res 2007, 313:1033-1044.
68. Lombardo Y., Scopelliti A., Cammareri P., et al. Bone morphogenetic protein 4 induces differentiation of colorectal cancer stem cells and increases their response to chemotherapy in mice. Gastroenterology 2011, 140:297-309.
69. Giacomini D., Páez-Pereda M., Theodoropoulou M., et al. Bone morphogenetic protein-4 inhibits corticotroph tumor cells: involvement in the retinoic acid inhibitory action. Endocrinology 2006, 147:247-256.
70. Johnson M.D., O'Connell M.J., Vito F., et al. Bone morphogenetic protein 4 and its receptors are expressed in the leptomeninges and meningiomas and signal via the Smad pathway. J Neuropathol Exp Neurol 2009, 68:1177-1183.
71. Davies S.R., Watkins G., Douglas-Jones A., et al. Bone morphogenetic proteins 1 to 7 in human breast cancer, expression pattern and clinical/prognostic relevance. J Exp Ther Oncol 2008, 7:327-338.
72. Rothhammer T., Poser I., Soncin F., et al. Bone morphogenic proteins are overexpressed in malignant melanoma and promote cell invasion and migration. Cancer Res 2005, 65:448-456.
73. Alarmo E.L., Kuukasjarvi T., Karhu R., et al. A comprehensive expression survey of bone morphogenetic proteins in breast cancer highlights the importance of BMP4 and BMP7. Breast Cancer Res Treat 2007, 103:239-246.
74. Guo D., Huang J., Gong J. Bone morphogenetic protein 4 (BMP4) is required for migrationand invasion of breast cancer. Mol Cell Biochem 2012, 363:179-190.
75. Guo X., Xiong L., Zou L., et al. Upregulation of bone morphogenetic protein 4 is associated with poor prognosis in patients with hepatocellular carcinoma. Pathol Oncol Res 2012, 18:635-640.
76. Hjertner O., Hjorth-Hansen H., Börset M., et al. Bone morphogenetic protein-4 inhibits proliferation and induces apoptosis of multiple myeloma cells. Blood 2001, 97:516-522.
77. Ketolainen J.M., Alarmo E.L., Tuominen V.J., et al. Parallel inhibition of cell growth and induction of cell migration and invasion in breast cancer cells by bone morphogenetic protein 4. Breast Cancer Res Treat 2010, 124:377-386.
78. Shirai Y.T., Ehata S., Yashiro M., et al. Bone morphogenetic protein-2 and -4 play tumor suppressive roles in human diffuse-type gastric carcinoma. Am J Pathol 2011, 179:2920-2930.
79. Buckley S., Shi W., Driscoll B., et al. BMP4 signaling induces senescence and modulates the oncogenic phenotype of A549 lung adenocarcinoma cells. Am J Physiol Lung Cell Mol Physiol 2004, 286:L81-L86.
80. Virtanen S., Alarmo E.L., Sandstrom S., et al. Bone morphogenetic protein -4 and -5 in pancreatic cancer-novel bidirectional players. Exp Cell Res 2011, 317:2136-2146.
81. Nishanian T.G., Kim J.S., Foxworth A., et al. Suppression of tumorigenesis and activation of Wnt signaling by bone morphogenetic protein 4 in human cancer cells. Cancer Biol Ther 2004, 3:667-675.
82. Maegdefrau U., Amann T., Winklmeier A., et al. Bone morphogenetic protein 4 is induced in hepatocellular carcinoma by hypoxia and promotes tumour progression. J Pathol 2009, 218:520-529.
83. Shepherd T.G., Nachtigal M.W. Identification of a putative autocrine bone morphogenetic protein-signaling pathway in human ovarian surface epithelium and ovarian cancer cells. Endocrinology 2003, 144:3306-3314.
84. Haubold M., Weise A., Stephan H. Bone morphogenetic protein 4 (BMP4) signaling in retinoblastoma cells. Int J Biol Sci 2010, 6:700-715.
85. Brubaker K.D., Corey E., Brown L.G., et al. Bone morphogenetic protein signaling in prostate cancer cell lines. J Cell Biochem 2004, 91:151-160.
86. Dai J., Keller J., Zhang J., et al. Bone morphogenetic protein-6 promotes osteoblastic prostate cancer bone metastases through a dual mechanism. Cancer Res 2005, 65:8274-8285.
87. Feeley B.T., Gamradt S.C., Hsu W.K., et al. Influence of BMPs on the formation of osteoblastic lesions in metastatic prostate cancer. J Bone Miner Res 2005, 20:2189-2199.
88. Shaw A., Gipp J., Bushman W. Exploration of Shh and BMP paracrine signaling in a prostate cancer xenograft. Differentiation 2010, 79:41-47.
89. Lee Y.C., Cheng C.J., Bilen M.A., et al. BMP4 promotes prostate tumor growth in bone through osteogenesis. Cancer Res 2011, 71:5194-5203.
90. Kim I.Y., Lee D.H., Lee D.K., et al. Restoration of bone morphogenetic protein receptor type II expression leads to a decreased rate of tumor growth in bladder transitional cell carcinoma cell line TSU-Pr1. Cancer Res 2004, 64:7355-7360.
91. Piccirillo S.G., Reynolds B.A., Zanetti N., et al. Bone morphogenetic proteins inhibit the tumorigenic potential of human brain tumour-initiating cells. Nature 2006, 444:761-765.
92. Iantosca M.R., McPherson C.E., Ho S.Y., et al. Bone morphogenetic proteins-2 and -4 attenuate apoptosis in a cerebellar primitive neuroectodermal tumor cell line. J Neurosci Res 1999, 56:248-258.
93. Zhao H., Ayrault O., Zindy F., et al. Post-transcriptional down-regulation of Atoh1/Math1 by bone morphogenic proteins suppresses medulloblastoma development. Genes Dev 2008, 22:722-727.
94. Zhou Z., Sun L., Wang Y., et al. Bone morphogenetic protein 4 inhibits cell proliferation and induces apoptosis in glioma stem cells. Cancer Biother Radiopharm 2011, 26:77-83.
95. Paez-Pereda M., Giacomini D., Refojo D., et al. Involvement of bone morphogenetic protein 4 (BMP-4) in pituitary prolactinoma pathogenesis through a Smad/estrogen receptor crosstalk. Proc Natl Acad Sci U S A 2003, 100:1034-1039.
96. Holien T., Våtsveen T.K., Hella H., et al. Bone morphogenetic proteins induce apoptosis in multiple myeloma cells by Smad-dependent repression of MYC. Leukemia 2012, 26:1073-1080.
97. Deng H., Ravikumar T.S., Yang W.L. Bone morphogenetic protein-4 inhibits heat-induced apoptosis by modulating MAPK pathways in human colon cancer HCT116 cells. Cancer Lett 2007, 256:207-217.
98. Martin-Belmonte F., Perez-Moreno M. Epithelial cell polarity, stem cells and cancer. Nat Rev Cancer 2011, 12:23-38.
99. Hamada S., Satoh K., Hirota M., et al. Bone morphogenetic protein 4 induces epithelial-mesenchymal transition through MSX2 induction on pancreatic cancer cell line. J Cell Physiol 2007, 213:768-774.
100. Gordon K.J., Kirkbride K.C., How T., et al. Bone morphogenetic proteins induce pancreatic cancer cell invasiveness through a Smad1-dependent mechanism that involves matrix metalloproteinase-2. Carcinogenesis 2009, 30:238-248.
101. Theriault B.L., Shepherd T.G., Mujoomdar M.L., et al. BMP4 induces EMT and Rho GTPase activation in human ovarian cancer cells. Carcinogenesis 2007, 28:1153-1162.
102. Deng H., Ravikumar T.S., Yang W.L. Overexpression of bone morphogenetic protein 4 enhances the invasiveness of Smad4-deficient human colorectal cancer cells. Cancer Lett 2009, 281:220-231.
103. Shon S.K., Kim A., Kim J.Y., et al. Bone morphogenetic protein-4 induced by NDRG2 expression inhibits MMP-9 activity in breast cancer cells. Biochem Biophys Res Commun 2009, 385:198-203.
104. Montesano R. Bone morphogenetic protein-4 abrogates lumen formation by mammary epithelial cells and promotes invasive growth. Biochem Biophys Res Commun 2007, 353:817-822.
105. Rothhammer T., Bataille F., Spruss T., et al. Functional implication of BMP4 expression on angiogenesis in malignant melanoma. Oncogene 2007, 26:4158-4170.
106. Farnsworth R.H., Karnezis T., Shayan R., et al. A role for bone morphogenetic protein-4 in lymph node vascular remodeling and primary tumor growth. Cancer Res 2011, 71:6547-6557.
107. David L., Feige J.J., Bailly S. Emerging role of bone morphogenetic proteins in angiogenesis. Cytokine Growth Factor Rev 2009, 20:203-212.
108. Kiyono M., Shibuya M. Bone morphogenetic protein 4 mediates apoptosis of capillary endothelial cells during rat pupillary membrane regression. Mol Cell Biol 2003, 23:4627-4636.
109. Suzuki Y., Montagne K., Nishihara A., et al. BMPs promote proliferation and migration of endothelial cells via stimulation of VEGF-A/VEGFR2 and angiopoietin-1/Tie2 signalling. J Biochem 2008, 143:199-206.
110. Weis S.M., Cheresh D.A. Tumor angiogenesis: molecular pathways and therapeutic targets. Nat Med 2011, 17:1359-1370.
111. Su D., Zhu S., Han X., et al. BMP4-Smad signaling pathway mediates adriamycin-induced premature senescence in lung cancer cells. J Biol Chem 2009, 284:12153-12164.
112. Musgrove E.A., Caldon C.E., Barraclough J., et al. Cyclin D as a therapeutic target in cancer. Nat Rev Cancer 2011, 11:558-572.
113. Malumbres M., Barbacid M. Cell cycle, CDKs and cancer: a changing paradigm. Nat Rev Cancer 2009, 9:153-166.
114. Jerde T.J., Wu Z., Theodorescu D., et al. Regulation of phosphatase homologue of tensin protein expression by bone morphogenetic proteins in prostate epithelial cells. Prostate 2011, 71:791-800.
115. Dai J., Hall C.L., Escara-Wilke J., et al. Prostate cancer induces bone metastasis through Wnt-induced bone morphogenetic protein-dependent and independent mechanisms. Cancer Res 2008, 68:5785-5794.
116. Kim J.S., Crooks H., Dracheva T., et al. Oncogenic beta-catenin is required for bone morphogenetic protein 4 expression in human cancer cells. Cancer Res 2002, 62:2744-2748.
117. Davis B.N., Hilyard A.C., Lagna G., Hata A. SMAD proteins control DROSHA-mediated microRNA maturation. Nature 2008, 454:56-61.
118. Ahmed M.I., Mardaryev A.N., Lewis C.J., et al. MicroRNA-21 is an important downstream component of BMP signalling in epidermal keratinocytes. J Cell Sci 2011, 124:3399-3404.
119. van Baal J.W., Verbeek R.E., Bus P., et al. microRNA-145 in Barrett's oesophagus: regulating BMP4 signalling via GATA6. Gut 2012, [Epub ahead of print].
120. Braig S., Mueller D.W., Rothhammer T., et al. MicroRNA miR-196a is a central regulator of HOX-B7 and BMP4 expression in malignant melanoma. Cell Mol Life Sci 2010, 67:3535-3548.
121. Norton J.D., Deed R.W., Craggs G., et al. Id helix-loop-helix proteins in cell growth and differentiation. Trends Cell Biol 1998, 8:58-65.
122. Rodriguez-Martinez A., Alarmo E.-L., Saarinen L., et al. Analysis of BMP4 and BMP7 signaling in breast cancer cells unveils time-dependent transcription patterns and highlights a common synexpression group of genes. BMC Med Genomics 2011, 4:80.